5BYK
Schistosoma mansoni (Blood Fluke) Sulfotransferase/S-oxamniquine Complex
Summary for 5BYK
Entry DOI | 10.2210/pdb5byk/pdb |
Related | 5BYJ |
Descriptor | Sulfotransferase, ADENOSINE-3'-5'-DIPHOSPHATE, {(2S)-7-nitro-2-[(propan-2-ylamino)methyl]-1,2,3,4-tetrahydroquinolin-6-yl}methanol, ... (5 entities in total) |
Functional Keywords | sulfotransferase, parasite, oxamniquine, drug resistance, transferase |
Biological source | Schistosoma mansoni (Blood fluke) |
Total number of polymer chains | 1 |
Total formula weight | 30810.07 |
Authors | Taylor, A.B.,Cao, X.,Holloway, S.P.,Hart, P.J. (deposition date: 2015-06-10, release date: 2015-09-30, Last modification date: 2024-10-16) |
Primary citation | Taylor, A.B.,Pica-Mattoccia, L.,Polcaro, C.M.,Donati, E.,Cao, X.,Basso, A.,Guidi, A.,Rugel, A.R.,Holloway, S.P.,Anderson, T.J.,Hart, P.J.,Cioli, D.,LoVerde, P.T. Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine. Plos Negl Trop Dis, 9:e0004132-e0004132, 2015 Cited by PubMed Abstract: For over two decades, a racemic mixture of oxamniquine (OXA) was administered to patients infected by Schistosoma mansoni, but whether one or both enantiomers exert antischistosomal activity was unknown. Recently, a ~30 kDa S. mansoni sulfotransferase (SmSULT) was identified as the target of OXA action. PubMed: 26485649DOI: 10.1371/journal.pntd.0004132 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.28 Å) |
Structure validation
Download full validation report